Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company sterna biologicals GmbH & Co. KG
DescriptionDNAyzme-based GATA binding protein 3 (GATA3) antagonist
Molecular Target GATA binding protein 3 (GATA3)
Mechanism of ActionGATA binding protein 3 (GATA3) antabonist
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationAsthma
Indication DetailsTreat allergic asthma
Regulatory Designation
PartnerVectura Group plc

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today